Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

This study has been completed.
Lymphoma Trials Office
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: May 2, 2000
Last updated: September 16, 2013
Last verified: March 2007